ArticleEMBO molecular medicine2019

ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer.

Mohamed I Saad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.